Llwytho...
Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation
Recently, scary viral pneumonia is known as (COVID-19) has swept the whole world. The new virus strain designated as SARS-CoV-2 belonging to the coronavirus family. Although the current medical research directed towards the development of a novel therapeutic agent, no anti-viral drug approved until...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Mol Liq |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Elsevier B.V.
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7399655/ https://ncbi.nlm.nih.gov/pubmed/32839634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molliq.2020.113968 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|